Categories: News

3X4 Genetics Names Michael Hubbard as CEO to Support Rapid US Growth

SEATTLE, June 15, 2021 /PRNewswire/ — 3X4 Genetics, a leader in the field of genetics-based health, today announced the appointment of Michael Hubbard as Chief Executive Officer.

Hubbard is an accomplished healthcare executive who brings more than 20 years of experience in the private and public sectors. Prior to joining 3X4 Genetics, Hubbard was the Chief Growth Officer at INDUS Technology, Inc. and the VP of Global Customer Experience at NuVasive, Inc.

3X4 Genetics is at the forefront of the emerging field of nutrigenetics and personalized health. As healthcare shifts to a more personalized approach, genetic testing offers health practitioners and the consumer, the ability to make personalized and actionable recommendations to live a healthier longer life.

“I am excited about the tremendous opportunity to bring actionable genetics information to more people around the world,” said Hubbard. “We have seen that technology provides an amazing amount of data to individuals so that they can better manage their health and performance. 3X4 is bringing genetics into this digital health realm and I see us as perfectly situated for rapid adoption.”

Founded by leading nutrigenetics pioneer Dr. Yael Joffe in 2018, 3X4 Genetics has developed a proprietary genetic test that’s sold through a network of accredited health practitioners. In addition to the tests, 3X4 Genetics provides health practitioners with training, resources, and a community of over 1,000 like-minded practitioners who share an interest in growing their practice and transforming more lives.

“We’re incredibly excited to have Michael lead us as we accelerate our growth plans in the US,” said Joffe. “We believe traditional education has left practitioners unprepared for the future of health and we’re committed to our mission to provide a turnkey solution that brings the power of genetic testing to their practice so they can lead their patients into this new personalized future.”

To find out more about 3X4 Genetics, visit www.3X4Genetics.com

About 3X4 Genetics: 

3X4 Genetics is a venture backed genetics-based foundational health company that combines advanced genetic testing, nutrigenomic education and a global network of accredited practitioners to help people listen to their bodies and make sound, daily choices to live longer, healthier and better lives.

Media: 

Brett@GoFrontlines.com 

Related Images

michael-hubbard-chief-executive.jpeg
Michael Hubbard, Chief Executive Officer, 3X4 Genetics

View original content to download multimedia:http://www.prnewswire.com/news-releases/3×4-genetics-names-michael-hubbard-as-ceo-to-support-rapid-us-growth-301312578.html

SOURCE 3X4 Genetics

Staff

Recent Posts

Teknova Announces Closing of $15.4 Million Private Placement

HOLLISTER, Calif., July 12, 2024 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a…

2 days ago

Faith In Young Champions: Hisense Partners with UEFA Foundation to Bring the Beautiful Game to Hospitalized Children

QINGDAO, China, July 12, 2024 /PRNewswire/ -- During the EURO 2024 tournament, the global home…

2 days ago

JANONE CONFIRMS NAME CHANGE TO ALT5 SIGMA CORPORATION AND NEW TICKER SYMBOL TO ALTS

LAS VEGAS, July 12, 2024 /PRNewswire/ -- JanOne Inc. (Nasdaq: JAN), a multidisciplinary organization with…

2 days ago

Hospital Español Auxilio Mutuo De Puerto Rico, Inc. Reports Network Breach

Important Notice About a Privacy MatterSAN JUAN, PUERTO RICO / ACCESSWIRE / July 12, 2024…

2 days ago

Nano Labs Announces Receipt of Deficiency Letters from Nasdaq

HANGZHOU, China, July 12, 2024 /PRNewswire/ -- Nano Labs Ltd (Nasdaq: NA) ("we," the "Company" or…

2 days ago

Inhance Technologies’ Statement in Response to EPA’s Section 6 Approach on Fluorination of Plastic Containers

HOUSTON, July 12, 2024 /PRNewswire/ -- Inhance Technologies welcomes the opportunity to engage with the…

2 days ago